Reads each study's design, patients, sites, publication type and dates, each cited.
- Never reads complaint, adverse event or surveillance records
- Never adds a study without its source file
CPT code application and LCD reconsideration planning that counts each study the way the Panel counts it and the way each Medicare contractor counts it, slides any deadline the evidence cannot meet, and leaves every replan and filing to named people.
Follow the registry that was only an abstract ↓A new procedure needs two separate yeses before most doctors are paid for it: a permanent code from the Panel, and coverage from each Medicare contractor whose policy still calls it investigational. Each reviewer reads the same studies by its own rule. A study that counts for one may not count for the other.
Today the evidence summary is rebuilt by hand for each packet, often by an outside consultancy. The team learns that a registry was only a conference abstract, or that a trial sits in the contractor's bibliography already, after the date has gone. Meanwhile a draft sentence that claims more than the cleared use is on its way out of the building.
Built forReimbursement directorsHealth economics leadsMedical affairs leadsCompliance reviewers
Two reviewers count the same studies by different rules, and a missing study shows up after the deadline has passed.
Done by hand today
Built-in controls
The director signs a plan the evidence can actually meet, and coverage requests file on their own date.
A mapping catheter's add-on procedure runs on a temporary code. The plan on the calendar files the permanent code application and three coverage requests on the same day, 19 days from now.
demoSample data: the company, its catheter, each study, each person and each date.
The calendar puts dates nobody at the company controls in the top rows: Panel meetings with their deadlines, valuation meetings, fee schedule rules and contractor clocks. The team's own work sits below. A note says the registry's acceptance letter came in, and the plan has not been checked against it.
He sorts the evidence and the agents run beside the calendar. Under the Panel rule the team loaded, it takes two full-text US studies with distinct patients. Only the randomized trial counts. The follow-up shares its patients, and the 1,184-patient registry is a conference abstract until it prints. For the contractors, three studies are new since their policy.
The study page shows what the agents quoted: an abstract with 1,184 adults at 38 US centers, and an acceptance letter saying the print issue comes later. Against the Panel rule it fails on published in full. Against the contractor rule it fails on a full-text copy. Either verdict can be challenged, with a reason.
The health economics manager sends the replan, and the director opens what moves before she can decide. The application slides to the last Panel meeting of the cycle, with no slack left. Society letters and the valuation survey slide with it. The coverage requests stay on their date, because they do not lean on the registry.
Her reason is plain: the evidence cannot make the earlier deadline. The signature means she approves the change to the filing dates. The calendar now shows the application on the later deadline with a refresh planned for when the registry prints, and a ghost block for the extension request if that date slips too.
The medical affairs lead opens each section in turn: the procedure and its cleared use, what counts for the Panel, what is new to the contractors, safety, and what was not counted and why. Safety is a signed input from her own team that the agents do not read. Only then can she approve it.
Each draft sentence was checked against the cleared indications. One overstates a trial's result, one calls a cleared catheter approved, one stretches to all ages. Each comes with a suggested rewrite and its source. The quoted sentences are signed by a sample, each opened against its source first.
The request names the sentence to delete, the language to add and the three new studies. Each jurisdiction gets its own letter and its own 60-day validity clock once filed. Filing stays locked until the flagged sentences are cleared and the sample is signed.
The same library, sorted by two rules. A study can fail one and pass the other.
| Study | Panel | Coverage requests |
|---|---|---|
| Randomized trial, 412 US patients | Counts | Already in the bibliography |
| Its 24-month follow-up | Same patients | New |
| Registry, 1,184 US patients | Abstract only | Abstract only |
| Randomized trial, 260 patients outside the US | Not US patients | New |
| Older-adult cohort, 318 patients | Not US patients | New |
| Pediatric case series | Outside the cleared use | Excluded |
demoSample data, from the working solution. The other eight are a sub-analysis, a feasibility study, bench data, a review, a poster, an editorial, a preprint and a budget model.
What the health economics team, compliance and the director look at between filings.
demoSample data, from the working solution.
They read, sort, check, plan and draft. People decide each date and each sentence.
Reads each study's design, patients, sites, publication type and dates, each cited.
Sorts each study by the loaded Category I rule, quoting the deciding passage.
Compares each study with each jurisdiction's bibliography and checks the full text is on file.
Checks each study and draft sentence against the cleared indications.
Loads fixed dates and slides blocks the evidence cannot make, with the knock-on.
Drafts the application, the request and the summary, citing only studies that count.
Watches the registry's print date, the Panel agenda and each contractor's postings.
The person who prepares an item never signs it.
A CPT code application asks the Panel for a code for a procedure, with a descriptor, a clinical vignette and the literature behind it. Here the evidence is counted first by the Panel's literature rule, so the team knows which meeting it can make before drafting for one.
Each contractor for Medicare and the Panel ask different questions of the same studies. Under the Panel rule your team loads, it takes full-text US studies with distinct patients; a contractor wants evidence that is new since its policy. One study can pass one and fail the other.
No. The cycle planner proposes the slide and shows what moves with it. The health economics manager sends the replan, and the reimbursement director accepts or declines it with a reason.
The on-label checker reads each draft sentence against the cleared indications and flags any that go further. A compliance reviewer clears the flagged ones and signs a sample of the rest after opening each against its source.
No. The safety section of the evidence summary arrives as a signed input from medical affairs, and drafts refer to it by number. Complaint, adverse event and surveillance records are never read.
From the application instructions your team loads, kept as a document with its version. The rule shown in settings is the one loaded, and a new version takes two signatures.
Bill each rental month with its proof, and know first which months fall short.
1-min demoDiagnostic Test Prior Authorization and AppealsAppeals that cite the line the payer missed, sent before the deadline.
1-min demoValue Analysis Committee DossierEach hospital's form answered in its order, with a sum the committee can check.
1-min demoWe will count each study by both rules and show which deadline it can make.